Expanding Fogarty's reach with NIH co-funding
Fogarty’s extramural grants are leveraged with considerable support from many NIH Institutes and Centers, expanding the reach and impact of its programs. Access the long description and source data.
Image
| Fiscal Year | FIC Extramural | Co-Funding | Notes |
|---|---|---|---|
| 1988 | 10,370,000 | ||
| 1989 | 10,540,000 | ||
| 1990 | 10,048,000 | 456,000 | |
| 1991 | 10,836,000 | 220,000 | |
| 1992 | 12,431,000 | 672,000 | |
| 1993 | 12,603,000 | 5,092,000 | |
| 1994 | 14,407,000 | 8,150,000 | |
| 1995 | 16,367,000 | 10,398,000 | |
| 1996 | 18,382,000 | 11,087,000 | |
| 1997 | 19,654,000 | 6,800,000 | |
| 1998 | 21,264,000 | 9,552,000 | |
| 1999 | 27,774,000 | 11,740,000 | |
| 2000 | 34,969,000 | 13,501,000 | |
| 2001 | 40,683,000 | 15,672,000 | |
| 2002 | 45,702,000 | 22,860,000 | |
| 2003 | 51,260,000 | 24,469,000 | |
| 2004 | 53,821,000 | 26,322,000 | |
| 2005 | 54,919,000 | 21,891,000 | |
| 2006 | 54,042,000 | 20,448,000 | |
| 2007 | 53,691,000 | 20,772,000 | |
| 2008 | 53,865,000 | 18,927,000 | |
| 2009 | 65,333,000 | 20,993,000 | Includes $10.2M in ARRA funds and $2.3M in PEPFAR and Pandemic flu co-funding |
| 2010 | 73,187,000 | 44,999,000 | Includes $30M in ARRA funds and $9.5M in MEPI and Pandemic flu co-funding |
| 2011 | 54,772,000 | 40,567,000 | Includes $18.3M in PEPFAR, MEPI and Pandemic flu co-funding |
| 2012 | 54,781,000 | 23,851,000 | Includes $4.2M in PEPFAR and MEPI co-funding |
| 2013 | 51,086,000 | 37,991,000 | Includes $21M in PEPFAR and MEPI co-funding |
| 2014 | 52,625,000 | 20,525,000 | |
| 2015 | 52,232,000 | 29,864,000 | Includes $10.2M in PEPFAR and MEPI co-funding |
| 2016 | 53,969,000 | 19,526,000 |